Skip to main content
NKTR logo
NKTR
(NASDAQ)
Nektar Therapeutics
$69.36-- (--)
Loading... - Market loading

Nektar Therapeutics (NKTR) Stock Price & Financial Analysis

Nektar Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$67.71 - $70.00
52-Week High$109.00
52-Week Low$21.02
Open$68.66
Volume631.07K
Average Volume (3M)1.07M
Market Cap1.72B
Shares Outstanding24.74M
Price to Sales (P/S)30.84
Price to Book (P/B)2.98
EV/EBITDA-13.92
Revenue (TTM)55.63M
Net Income (TTM)-158.10M
Free Cash Flow (TTM)-203.94M
EPS (TTM)$-8.10
Profit Margin-284.18%
Operating Margin-224.08%
Return on Equity (ROE)-27.44%
Debt to Equity0.25
50-Day MA$65.97
200-Day MA$62.61
52-Week Change177.44%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Nektar Therapeutics

What is the current stock price for NKTR?

As of the latest trading session, NKTR stock trades at $69.36. The 52-week range is $21.02–$109.00, with a day range of $67.71–$70.00.

What is the P/E ratio for NKTR?

The P/E ratio (Price-to-Earnings) for NKTR is shown in the Key Statistics section. This valuation metric helps compare Nektar Therapeutics to industry peers.

Does NKTR pay dividends?

Nektar Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NKTR?

Based on 8 analysts, the consensus for NKTR is Buy.

What is the market cap of NKTR?

Nektar Therapeutics's market capitalization is $1.72B, classifying it as a small-cap company. Nektar Therapeutics operates in the Healthcare sector within the Biotechnology industry.